ARHGDIA
Rho GDP dissociation inhibitor (GDI) alpha
ARHGDIA; Rho GDP dissociation inhibitor (GDI) alpha; GDIA1; rho GDP-dissociation inhibitor 1; RHOGDI; rho GDI 1; rho-GDI alpha; RHOGDI-1; MGC117248;
ARHGDIB
Rho GDP dissociation inhibitor (GDI) beta
ARHGDIB; Rho GDP dissociation inhibitor (GDI) beta; GDIA2, GDID4, RAP1GN1; rho GDP-dissociation inhibitor 2; Ly GDI; RhoGDI2; Rho GDI 2; rho-GDI beta; D4; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1;
CCS
copper chaperone for superoxide dismutase
CCS; copper chaperone for superoxide dismutase; superoxide dismutase copper chaperone; MGC138260;
DDR1
discoidin domain receptor tyrosine kinase 1
DDR1; discoidin domain receptor tyrosine kinase 1; CAK, discoidin domain receptor family, member 1 , EDDR1, NEP, NTRK4, PTK3A; epithelial discoidin domain-containing receptor 1; CD167; RTK6; tyrosine kinase DDR; cell adhesion kinase; mammary carcinoma ki;
Ddr2
discoidin domain receptor tyrosine kinase 2
DDR2; discoidin domain receptor tyrosine kinase 2; TKT; MIG20a; NTRKR3; TYRO10; discoidin domain-containing receptor 2; tyrosylprotein kinase; hydroxyaryl-protein kinase; discoidin domain receptor 2; tyrosine-protein kinase TYRO10; CD167 antigen-like family member B; cell migration-inducing protein 20; migration-inducing gene 16 protein; receptor protein-tyrosine kinase TKT; discoidin domain receptor family, member 2; neurotrophic tyrosine kinase receptor related 3; neurotrophic tyrosine kinase, receptor-related 3; discoidin domain-containing receptor tyrosine kinase 2;
DLX5
distal-less homeobox 5
DLX5; distal-less homeobox 5; distal less homeo box 5; homeobox protein DLX-5; distal-less homeo box 5; split hand/foot malformation type 1 with sensorineural hearing loss; SHFM1D;
GDI1
GDP dissociation inhibitor 1
GDI1; GDP dissociation inhibitor 1; rab GDP dissociation inhibitor alpha; FLJ41411; GDI-1; GDIA_HUMAN; Guanosine diphosphate dissociation inhibitor 1; Mental retardation X-linked 41; Mental retardation X-linked 48; MRX41; MRX48; Oligophrenin 2; Oligophrenin-2; OPHN2; Protein XAP 4; Protein XAP-4; Protein XAP4; Rab GDI alpha; RABGD1A; RABGDIA; XAP 4; SMG p25A GDI;
GDI2
GDP dissociation inhibitor 2
GDI2; GDP dissociation inhibitor 2; rab GDP dissociation inhibitor beta; rab GDP dissociation; RABGDIB; GDI-2; GDIB_HUMAN; Guanosine diphosphate dissociation inhibitor 2; Rab GDI beta; rab GDP-dissociation inhibitor, beta;
NDE1
nudE nuclear distribution gene E homolog 1 (A. nidulans)
NDE1; nudE nuclear distribution gene E homolog 1 (A. nidulans); nuclear distribution protein nudE homolog 1; FLJ20101; NUDE; HOM TES 87; LIS1 interacting protein NUDE1rat homolog; LIS1 interacting protein NUDE1; NDE 1; NDE1_HUMAN; Nuclear distribution gene E homolog 1; NUDE 1; NudE nuclear distribution gene E homolog 1; NUDE1; OTTHUMP00000160329; OTTHUMP00000160330; LIS1-interacting protein NUDE1, rat homolog; LIS4; HOM-TES-87;
PDIA2
protein disulfide isomerase family A, member 2
PDIA2; protein disulfide isomerase family A, member 2; PDIP, protein disulfide isomerase, pancreatic , protein disulfide isomerase associated 2; protein disulfide-isomerase A2; PDA2; PDI; PDIR; protein disulfide isomerase A2; Rho GDP dissociation inhibi;
PDIA3
protein disulfide isomerase family A, member 3
PDIA3; protein disulfide isomerase family A, member 3; P58; ER60; ERp57; ERp60; ERp61; GRP57; GRP58; PI-PLC; HsT17083; HEL-S-269; HEL-S-93n; protein disulfide-isomerase A3; ER protein 57; ER protein 60; phospholipase C-alpha; 58 kDa microsomal protein; disulfide isomerase ER-60; endoplasmic reticulum P58; 58 kDa glucose-regulated protein; glucose regulated protein, 58kDa; epididymis secretory protein Li 269; protein disulfide isomerase-associated 3; endoplasmic reticulum resident protein 57; endoplasmic reticulum resident protein 60; epididymis secretory sperm binding protein Li 93n;
PDIA4
protein disulfide isomerase family A, member 4
PDIA4; protein disulfide isomerase family A, member 4; ERP70; ERP72; ERp-72; protein disulfide-isomerase A4; ER protein 70; ER protein 72; protein disulfide isomerase-associated 4; endoplasmic reticulum resident protein 70; endoplasmic reticulum resident protein 72; protein disulfide isomerase related protein (calcium-binding protein, intestinal-related);
PDIA6
protein disulfide isomerase family A, member 6
PDIA6; protein disulfide isomerase family A, member 6; protein disulfide isomerase associated 6 , thioredoxin domain containing 7 (protein disulfide isomerase) , TXNDC7; protein disulfide-isomerase A6; ERp5; P5; protein disulfide isomerase related protein; Endoplasmic reticulum protein 5; Protein disulfide isomerase A6; Protein disulfide isomerase associated 6; Protein disulfide isomerase family A member 6; Protein disulfide isomerase P5; Thioredoxin domain containing 7 (protein disulfide isomerase); Thioredoxin domain containing protein 7; TXNDC7; ER protein 5; thioredoxin domain-containing protein 7; protein disulfide isomerase-associated 6; protein disulfide isomerase-related protein;
PKD2
polycystic kidney disease 2 (autosomal dominant)
PKD2; polycystic kidney disease 2 (autosomal dominant); polycystin-2; Pc 2; PC2; PKD4; transient receptor potential cation channel; subfamily P; member 2; TRPP2; R48321; polycystwin; autosomal dominant polycystic kidney disease type II protein; transient receptor potential cation channel, subfamily P, member 2; Pc-2; APKD2; MGC138466; MGC138468;
RALGDS
ral guanine nucleotide dissociation stimulator
RALGDS; ral guanine nucleotide dissociation stimulator; RGF; RGDS; RalGEF; ral guanine nucleotide exchange factor;
SOD1
superoxide dismutase 1, soluble
SOD1; superoxide dismutase 1, soluble; ALS; SOD; ALS1; IPOA; hSod1; HEL-S-44; homodimer; superoxide dismutase [Cu-Zn]; SOD, soluble; indophenoloxidase A; Cu/Zn superoxide dismutase; superoxide dismutase, cystolic; epididymis secretory protein Li 44;
SOD2
superoxide dismutase 2, mitochondrial
SOD2; superoxide dismutase 2, mitochondrial; IPOB; MNSOD; MVCD6; superoxide dismutase [Mn], mitochondrial; indophenoloxidase B; Mn superoxide dismutase; mangano-superoxide dismutase; manganese-containing superoxide dismutase;
PKHD1
polycystic kidney and hepatic disease 1 (autosomal recessive)
PKHD1; polycystic kidney and hepatic disease 1 (autosomal recessive); FCYT; ARPKD; TIGM1; fibrocystin; tigmin; polyductin; TIG multiple domains 1; polycystic kidney and hepatic disease 1 protein; Fibrocystin; Polycystic kidney and hepatic disease 1 protein; Polyductin; Tigmin;
DAB1
disabled homolog 1
DAB1; disabled homolog 1 (Drosophila); disabled (Drosophila) homolog 1; disabled homolog 1;
CAND1
cullin-associated and neddylation-dissociated 1
cullin-associated NEDD8-dissociated protein 1 p120 CAND1; OTTHUMP00000240019; TBP interacting protein; TBP-interacting protein 120A; TBP-interacting protein of 120 kDa A; cullin-associated and neddylation-dissociated protein 1; CAND1;
DLG4
Dlg4 discs, large homolog 4 (Drosophila)
DLG4; discs, large homolog 4 (Drosophila); disks large homolog 4; SAP-90; PSD-95 beta; PSD-95 alpha 2b; discs large homolog 4; synapse-associated protein 90; postsynaptic density protein 95; Dlgh4; PSD95; SAP90; PSD-95; SAP90A;
DLX2
distal-less homeobox 2
DLX2; distal-less homeobox 2; homeobox protein DLX-2; DII A; homeobox protein TES-1; Dlx-2; Tes-1; AW121999;
DLX3
distal-less homeobox 3
DLX3; distal-less homeobox 3; distal less homeo box 3; homeobox protein DLX-3; AI4; distal-less homeo box 3; DLX 3; DLX3_HUMAN; Homeobox protein DLX 3; TDO; OTTHUMP00000220808;
DLX4
distal-less homeobox 4
DLX4; distal-less homeobox 4; DLX7, DLX9; homeobox protein DLX-4; BP1; DLX8; beta protein 1; homeobox protein DLX-7; homeobox protein DLX-8; distal-less homeo box 7; distal-less homeo box 9; DLX7; DLX9;
DVL3
dishevelled segment polarity protein 3
DVL3; dishevelled segment polarity protein 3; segment polarity protein dishevelled homolog DVL-3; DSH homolog 3; dishevelled-3; dishevelled, dsh homolog 3; dishevelled 3 (homologous to Drosophila dsh);
NPC1
Niemann-Pick disease, type C1
NPC1; Niemann-Pick disease, type C1; Niemann-Pick C1 protein; NPC; FLJ98532; Cdig2;
NUDC
nuclear distribution gene C homolog (A. nidulans)
NUDC; nuclear distribution gene C homolog (A. nidulans); nuclear distribution gene C (A.nidulans) homolog; nuclear migration protein nudC; HNUDC; MNUDC; MNUDC protein; NPD011; Nuclear distribution gene C homolog; Nuclear distribution protein C homolog; NUDC_HUMAN; OTTHUMP00000004405; SIG 92; SIG92;
PDIA5
protein disulfide isomerase family A, member 5
PDIA5; protein disulfide isomerase family A, member 5; protein disulfide isomerase associated 5; protein disulfide-isomerase A5; FLJ30401; PDIR; PDIA5_HUMAN; Protein disulfide isomerase related; Protein disulfide isomerase-related protein; OTTHUMP00000215811; OTTHUMP00000215812; protein disulfide isomerase-associated 5;
PSEN2
presenilin 2 (Alzheimer disease 4)
PSEN2; AD4; PS2; AD3L; AD3LP; STM2; CMD1V; presenilin 2 (Alzheimer disease 4); presenilin 2; presenilin-2; AD5; E5-1; PS-2; STM-2; OTTHUMP00000035671; OTTHUMP00000035672; OTTHUMP00000228286; OTTHUMP00000228288; EC 3.4.23.-; EC 3.4.23; PSNL2;
RGL1
ral guanine nucleotide dissociation stimulator-like 1
RGL1; ral guanine nucleotide dissociation stimulator-like 1; RGL; ralGDS-like 1; KIAA0959;
RGL2
ral guanine nucleotide dissociation stimulator-like 2
RGL2; ral guanine nucleotide dissociation stimulator-like 2; RAB2, member RAS oncogene family like , RAB2L; HKE1.5; KE1.5; RAB2L; RalGDS-like 2; RalGDS-like factor; Ras-associated protein RAB2L; RGL2_HUMAN; OTTHUMP00000029085; GDS-related protein;
SOD3
superoxide dismutase 3, extracellular
SOD3; superoxide dismutase 3, extracellular; EC-SOD; extracellular superoxide dismutase [Cu-Zn];
WFDC2
WAP four-disulfide core domain 2
WFDC2; WAP four-disulfide core domain 2; HE4; WAP5; EDDM4; dJ461P17.6; WAP four-disulfide core domain protein 2; epididymal protein 4; epididymal secretory protein E4; putative protease inhibitor WAP5; WAP domain containing protein HE4-V4; major epididymis-specific protein E4; epididymis-specific, whey-acidic protein type, four-disulfide core;
DLG3
Dlg3 discs, large homolog 3 (Drosophila)
DLG3; discs, large homolog 3 (Drosophila); disks large homolog 3; SAP-102; discs large homolog 3; synapse-associated protein 102; Dlgh3; SAP102; mKIAA1232;
NDEL1
nudE nuclear distribution E homolog (A. nidulans)-like 1
NDEL1; nudE nuclear distribution E homolog (A. nidulans)-like 1; nudE nuclear distribution gene E homolog (A. nidulans) like 1; nuclear distribution protein nudE-like 1; MITAP1; NUDEL; protein Nudel; endooligopeptidase A; mitosin-associated protein 1; mit;
ARHGDIG
Rho GDP dissociation inhibitor (GDI) gamma
ARHGDIG; Rho GDP dissociation inhibitor (GDI) gamma; rho GDP-dissociation inhibitor 3; RhoGDI gamma; RHOGDI 3; GDIR3_HUMAN; OTTHUMP00000067353; OTTHUMP00000194914; Rho GDI 3; Rho GDI gamma; Rho GDP dissociation inhibitor 3; Rho GDP dissociation inhibitor gamma; Rho-GDI gamma; RHOGDI3; OTTHUMP00000067352; RHOGDI-3;
DCBLD2
discoidin, CUB and LCCL domain containing 2
DCBLD2; discoidin, CUB and LCCL domain containing 2; discoidin, CUB and LCCL domain-containing protein 2; CLCP1; ESDN; 1700055P21Rik; coagulation factor V/VIII-homology domains protein 1; CUB, LCCL and coagulation factor V/VIII-homology domains protein 1;
DIP2A
DIP2 disco-interacting protein 2 homolog A (Drosophila)
DIP2A; DIP2 disco-interacting protein 2 homolog A (Drosophila); C21orf106, chromosome 21 open reading frame 106; disco-interacting protein 2 homolog A; Dip2; KIAA0184; C21orf106; DIP 2A; DIP2 disco interacting protein 2 homolog A; DIP2 homolog A; DIP2 like protein; Disco interacting protein 2 homolog; disco-interacting protein 2A;
DIS3
DIS3 mitotic control homolog (S. cerevisiae)
DIS3; DIS3 mitotic control homolog (S. cerevisiae); KIAA1008; exosome complex exonuclease RRP44; dis3p; EXOSC11; exosome component 11; RRP44; Mitotic control protein dis3 homolog; Protein DIS3 homolog; Ribosomal RNA processing protein 44; Ribosomal RNA-processing protein 44; RRP44_HUMAN; 2810028N01Rik; bA555G22.1; RP11-342J4.3;
DLG1
discs, large homolog 1 (Drosophila)
DLG1; discs, large homolog 1 (Drosophila); discs, large (Drosophila) homolog 1; disks large homolog 1; discs large homolog 1; dJ1061C18.1.1; DLGH1; hdlg; presynaptic protein SAP97; SAP 97; SAP97; synapse associated protein 97; synapse-associated protein 97; SAP-97; DKFZp761P0818; DKFZp781B0426;
DLG5
discs, large homolog 5 (Drosophila)
DLG5; discs, large homolog 5 (Drosophila); discs, large (Drosophila) homolog 5; disks large homolog 5; KIAA0583; P dlg; Discs large homolog 5 (Drosophila); Discs large homolog 5; Discs large protein LP DLG; Discs large protein P dlg; Discs large protein P-dlg; DLG 5; DLG5_HUMAN; Large type of P DLG; LP DLG; P DLG5; PDLG; Placenta and prostate DLG; OTTHUMP00000019917; OTTHUMP00000019918; large type of P-DLG; discs large protein LP-DLG; LP-DLG; P-DLG5;
DLX6
distal-less homeobox 6
DLX6; distal-less homeobox 6; Distal less homeo box 6; Distal less homeobox 6; Distal less homeobox gene 6a; DLX6_HUMAN; Homeobox protein DLX-6; MGC125282; MGC125283; MGC125284; MGC125285; OTTHUMP00000205294; RGD1561539;
EDIL3
EGF-like repeats and discoidin I-like domains 3
EDIL3; EGF-like repeats and discoidin I-like domains 3; DEL1; EGF-like repeat and discoidin I-like domain-containing protein 3; integrin-binding protein DEL1; developmental endothelial locus-1; developmentally-regulated endothelial cell locus 1 protein;
EPM2A
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
EPM2A; epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); epilepsy, progressive myoclonus type 2, Lafora disease (laforin); laforin; LD; LDE; LAFPTPase; lafora PTPase; EPM2; MELF;
NPC2
Niemann-Pick disease, type C2
NPC2; Niemann-Pick disease, type C2; HE1; EDDM1; epididymal secretory protein E1; epididymal protein 1; tissue-specific secretory protein; human epididymis-specific protein 1; Niemann-Pick disease type C2 protein;
PKD1L2
polycystic kidney disease 1-like 2
PKD1L2; polycystic kidney disease 1-like 2; polycystic kidney disease protein 1-like 2; KIAA1879; PC1 like 2 protein; PKD1L 2; Polycystic kidney disease 1 like protein 2; Polycystin 1 like 2; polycystin-1L2; OTTHUMP00000231957; OTTHUMP00000231959; OTTHUMP00000231961; PC1-like 2 protein; PC1L2;
PKD2L1
polycystic kidney disease 2-like 1
PKD2L1; polycystic kidney disease 2-like 1; PKD2L, PKDL; polycystic kidney disease 2-like 1 protein; PCL; transient receptor potential cation channel; subfamily P; member 3; TRPP3; B830002B15; BC046386; PK2L1; PK2L1_HUMAN; PKD2L; PKDL; Polycystic kidney disease 2 like 1 protein; Polycystin L; Polycystin-2 homolog; Polycystin-2L1; Polycystin-L; Polycystin-L1; transient receptor potential cation channel, subfamily P, member 3;
SLC25A16
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16
SLC25A16; solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16; graves disease carrier protein; D10S105E; GDA; HGT.1; ML7; graves disease autoantigen; solute carrier family 25 member 16; mitochondrial solute carrier prot;
WFDC3
WAP four-disulfide core domain 3
WFDC3;WAP four-disulfide core domain 3;WAP four-disulfide core domain protein 3;dJ447F3.3;WAP14;whey acidic protein 14;protease inhibitor WAP14;putative protease inhibitor WAP14;
WFDC5
WAP four-disulfide core domain 5
WFDC5; WAP four-disulfide core domain 5; WAP four-disulfide core domain protein 5; dJ211D12.5; WAP1; p53 responsive gene 5; p53 responsive gene 5 protein; p53-responsive gene 5; p53-responsive gene 5 protein; PRG5; Protease inhibitor WAP1; Putative protease inhibitor WAP1; WAP four disulfide core domain 5;
HRP
Horseradish peroxidase
Peroxidase; Peroxidase (Horseradish); PANCA; PEROXIDASE (MYELOPEROXIDASE), LEUKOCYTE; PEROXIDASE, SALT FREE; PEROXIDASE HORSERADISH; PEROXIDASE, INACTIVATED; PEROXIDASE TYPE I; PEROXIDASE TYPE II; PEROXIDASE TYPE VI; EC 1.11.1.7; Horseradish Peroxidase; HPRC 1; HPRC1; HRP; HRPA2; HRPC 2; HRPC2; HRPE5; HRPN; Neutral peroxidase; Peroxidase A2; Peroxidase; Peroxidase C1A; Peroxidase C1B; Peroxidase C2; Peroxidase C3; Peroxidase E5; Peroxidase N; PRXC1A; PRXC1B; PRXC2; PRXC3;
PKHD1L1
polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1
PKHD1L1;polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1;fibrocystin-L;fibrocystin L;PKHD1-like protein 1;polycystic kidney and hepatic disease-like 1;polycystic kidney and hepatic disease 1-like protein 1;PKHDL1;DKFZp586C1021;
DLG2
Dlg2 discs, large homolog 2 (Drosophila)
DLG2; discs, large homolog 2 (Drosophila); disks large homolog 2; chapsyn-110; postsynaptic density protein PSD-93; channel-associated protein of synapse-110; Dlgh2; PSD93; Gm1197; A330103J02Rik; B230218P12Rik; B330007M19Rik;
DIS3L2
DIS3 mitotic control homolog (S. cerevisiae)-like 2
DIS3L2; DIS3 mitotic control homolog (S. cerevisiae)-like 2; FAM6A, family with sequence similarity 6, member A; DIS3-like exonuclease 2; FLJ36974; MGC42174; DIS3 L2; DIS3 mitotic control homolog (S. cerevisiae) like 2; DIS3 mitotic control homolog like 2; family with sequence similarity 6, member A; FAM6A;
DLGAP4
discs, large (Drosophila) homolog-associated protein 4
DLGAP4; discs, large (Drosophila) homolog-associated protein 4; disks large-associated protein 4; DAP4; KIAA0964; SAPAP4; DAP 4; DAP-4; Disks large associated protein 4; DLGP4_HUMAN; PSD 95/SAP90 binding protein 4; PSD-95/SAP90-binding protein 4; SAP90/PSD-95-associated protein 4; SAPAP 4; SAPAP-4; DLP4; RP5-977B1.6;
DVL1
dishevelled, dsh homolog 1 (Drosophila)
DVL1; dishevelled, dsh homolog 1 (Drosophila); dishevelled 1 (homologous to Drosophila dsh); segment polarity protein dishevelled homolog DVL-1; Dishevelled 1; dishevelled 1 like; Dishevelled; Dishevelled dsh homolog 1; Dishevelled-1; Dishevelled1; DSH homolog 1; Dvl 1; Dvl; DVL1_HUMAN; DVL1L1; MGC54245; Segment polarity protein dishevelled homolog DVL 1; segment polarity protein dishevelled homolog DVL 1 like; Segment polarity protein dishevelled homolog DVL1;
ENOX1
ecto-NOX disulfide-thiol exchanger 1
ENOX1; ecto-NOX disulfide-thiol exchanger 1; cCNOX; CNOX; FLJ10094; PIG38; bA64J21.1; Candidate growth related and time keeping constitutive hydroquinone [NADH] oxidase; Cell proliferation inducing gene 38 protein; Constitutive Ecto NOX; Ecto NOX disulfide thiol exchanger 1; OTTHUMP00000018332; Proliferation inducing protein 38; constitutive Ecto-NOX; cell proliferation-inducing gene 38 protein; candidate growth-related and time keeping constitutive hydroquinone (NADH) oxidase; candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase;
MN1
meningioma (disrupted in balanced translocation) 1
MN1; meningioma (disrupted in balanced translocation) 1; meningioma chromosome region , MGCR; probable tumor suppressor protein MN1; MGCR1; MGCR1 PEN; meningioma chromosome region 1; meningioma (translocation balanced); MGCR; MGCR1-PEN; dJ353E16.2;
Dact1
dishevelled-binding antagonist of beta-catenin 1
DACT1; dishevelled-binding antagonist of beta-catenin 1; DPR1; FRODO; HDPR1; DAPPER; THYEX3; DAPPER1; dapper homolog 1; dapper antagonist of catenin 1; heptacellular carcinoma novel gene 3; dapper, antagonist of beta-catenin, homolog 1; hepatocellular carcinoma novel gene 3 protein;
DISC1
disrupted in schizophrenia 1
DISC1; disrupted in schizophrenia 1; disrupted in schizophrenia 1 protein; SCZD9; C1orf136; FLJ13381; FLJ21640; FLJ25311; FLJ41105; KIAA0457;
ADAM21
a disintegrin and metallopeptidase domain 21
ADAM21; a disintegrin and metallopeptidase domain 21; Adam31; disintegrin and metalloproteinase domain-containing protein 21; ADAM 21; ADAM 31; a disintegrin and metalloprotease domain 21; a disintegrin and metalloprotease domain (ADAM) 21; disintegrin and metalloproteinase domain-containing protein 31;
DAAM1
dishevelled associated activator of morphogenesis 1
DAAM1; dishevelled associated activator of morphogenesis 1; disheveled-associated activator of morphogenesis 1; KIAA0666; FLJ41657;
DAAM2
dishevelled associated activator of morphogenesis 2
DAAM2; dishevelled associated activator of morphogenesis 2; disheveled-associated activator of morphogenesis 2; KIAA0381; dishevelled-associated activator of morphogenesis 2; dJ90A20A.1; RP1-278E11.1; MGC90515;
DIS3L
DIS3 mitotic control homolog (S. cerevisiae)-like
DIS3L; DIS3 mitotic control homolog (S. cerevisiae)-like; DIS3-like exonuclease 1; FLJ38088; KIAA1955; MGC4562; DIS3 like exonuclease 1; DIS3 mitotic control homolog (S. cerevisiae) like; DIS3L1;
DLGAP1
discs, large homolog-associated protein 1
DLGAP1; discs, large (Drosophila) homolog-associated protein 1; discs, large (Drosophila) homolog associated protein 1; disks large-associated protein 1; DAP 1; GKAP; SAPAP1; PSD-95/SAP90 binding protein 1; SAP90/PSD-95-associated protein 1; guanylate kin;
DVL2
dishevelled, dsh homolog 2
DVL2; dishevelled, dsh homolog 2 (Drosophila); dishevelled 2 (homologous to Drosophila dsh); segment polarity protein dishevelled homolog DVL-2; DSH homolog 2; dishevelled-2;
DISP2
dispatched homolog 2 (Drosophila)
DISP2; dispatched homolog 2 (Drosophila); protein dispatched homolog 2; DISPB; HsT16908; KIAA1742; DISP 2; Dispatched B; Dispatched homolog 2; DKFZp547N223;
DIP2B
DIP2 disco-interacting protein 2 homolog B (Drosophila)
DIP2B; DIP2 disco-interacting protein 2 homolog B (Drosophila); disco-interacting protein 2 homolog B; FLJ34278; KIAA1463; DIP2; Disco interacting protein 2 homolog B; MGC104005; OTTHUMP00000241215;
DLGAP5
discs, large homolog-associated protein 5
DLGAP5; discs, large (Drosophila) homolog-associated protein 5; discs, large homolog 7 (Drosophila) , DLG7; disks large-associated protein 5; DLG1; HURP; KIAA0008; DAP-5; discs large homolog 7; discs, large homolog 7; hepatoma up-regulated protein; disks;
NDP
Norrie disease (pseudoglioma)
NDP; Norrie disease (pseudoglioma); EVR2, exudative vitreoretinopathy 2 (X linked); norrin; EVR2; Exudative vitreoretinopathy 2 (X linked); FEVR; ND; NDP_HUMAN; Norrie disease protein; Norrin precursor; X linked exudative vitreoretinopathy 2 protein; X-linked exudative vitreoretinopathy 2 protein;
PDILT
protein disulfide isomerase-like, testis expressed
PDILT; protein disulfide isomerase-like, testis expressed; protein disulfide-isomerase-like protein of the testis; PDIA7; protein disulfide isomerase family A; member 7; protein disulfide isomerase like protein of the testis; protein disulfide isomerase f;
PKD2L2
polycystic kidney disease 2-like 2
PKD2L2; polycystic kidney disease 2-like 2; polycystic kidney disease 2-like 2 protein; polycystic kidney disease 2 like 2; Polycystin L2; TRPP5; polycystin-L2; polycystin-2L2; Polycystin - L2;
PKD1L3
polycystic kidney disease 1-like 3
PKD1L3; polycystic kidney disease 1-like 3; polycystic kidney disease protein 1-like 3; PC1 like 3 protein; Polycystic kidney disease 1 like 3; Polycystic kidney disease protein 1 like 3; Polycystin 1 like 3; Polycystin 1L3; polycystin-1L3; PC1-like 3 protein;
PKDREJ
polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin)
PKDREJ; polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin); polycystic kidney disease (polycystin) and REJ (sperm receptor for egg jelly homolog, sea urchin) like , polycystic kidney disease (polycys;
PYROXD2
pyridine nucleotide-disulphide oxidoreductase domain 2
PYROXD2; pyridine nucleotide-disulphide oxidoreductase domain 2; C10orf33, chromosome 10 open reading frame 33; pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2; FLJ23849; C10orf33; FP3420; Pyridine nucleotide disulphide oxidoreductase domain 2;
PKD1
polycystic kidney disease 1 (autosomal dominant)
PKD1; polycystic kidney disease 1 (autosomal dominant); polycystin-1; PBP; Pc 1; polycystin 1; transient receptor potential cation channel; subfamily P; member 1; TRPP1; Autosomal dominant polycystic kidney disease 1 protein; Autosomal dominant polycystic kidney disease protein 1; OTTHUMP00000208669; OTTHUMP00000208670; Pc-1; PKD; PKD1_HUMAN; Polycystic Kidney Disease 1; polycystic kidney disease-associated protein; Polycystin 1 Precursor; transient receptor potential cation channel, subfamily P, member 1;
PKD1L1
polycystic kidney disease 1 like 1
PKD1L1; polycystic kidney disease 1 like 1; polycystic kidney disease protein 1-like 1; polycystin 1L1; PRO19563; polycystin-1L1; PC1-like 1 protein;
RAP1GDS1
RAP1, GTP-GDP dissociation stimulator 1
RAP1GDS1; RAP1, GTP-GDP dissociation stimulator 1; rap1 GTPase-GDP dissociation stimulator 1; SmgGDS; Exchange factor smgGDS; GDS1; GTP-GDP dissociation stimulator 1; Highly similar to RAP1 GTPASE-GDP DISSOCIATION STIMULATOR 1; MGC118859; MGC118861; RAP1; SMG GDS protein; SMG P21 stimulatory GDP/GTP exchange protein;
RGL3
ral guanine nucleotide dissociation stimulator-like 3
RGL3; ral guanine nucleotide dissociation stimulator-like 3; FLJ32585; ralGDS-like 3; RalGEF-like protein 3, mouse homolog; FLJ00153; FLJ44275; MGC126805; MGC138163;
RGL4
ral guanine nucleotide dissociation stimulator-like 4
RGL4; ral guanine nucleotide dissociation stimulator-like 4; ral-GDS-related protein; RalGDS related oncogene; Rgr; hRGR; MGC119678; MGC119680; Ral GDS related protein; RalGDS like 4; ralGDS-like 4; Ral-GDS related protein Rgr;
WFDC12
WAP four-disulfide core domain 12
WFDC12; WAP four-disulfide core domain 12; C20orf122, chromosome 20 open reading frame 122; WAP four-disulfide core domain protein 12; dJ211D12.4; WAP2; Putative protease inhibitor WAP12; WFD12_HUMAN; Whey acidic protein 2; protease inhibitor WAP2; single WAP motif protein 2; SWAM2; C20orf122;
WFDC9
WAP four-disulfide core domain 9
WFDC9; WAP four-disulfide core domain 9; protein WFDC9; dJ688G8.2; WAP9; MGC126701; MGC126705; WFDC9_HUMAN;
WFDC1
WAP four-disulfide core domain 1
WFDC1; WAP four-disulfide core domain 1; WAP four-disulfide core domain protein 1; PS20; ps20 growth inhibitor; prostate stromal protein ps20; WAP four-disulfide core domain 1 homolog;
CAND2
cullin-associated and neddylation-dissociated 2 (putative)
CAND2; cullin-associated; neddylation-dissociated 2 (putative); Tp120b; TIP120B; KIAA0667; cullin-associated NEDD8-dissociated protein 2; p120 CAND2; OTTHUMP00000207913; OTTHUMP00000209387; TBP interacting protein; TBP-interacting protein 120B; epididymis tissue protein Li 169; TBP-interacting protein of 120 kDa B; cullin-associated and neddylation-dissociated protein 2;
PDDC1
Parkinson disease 7 domain containing 1
PDDC1;Parkinson disease 7 domain containing 1;26616;ENSG00000177225;11p15.5;FLJ34283, FLJ35497, MGC131881, MGC138350;Parkinson disease 7 domain-containing protein 1;Parkinson disease 7 domain-containing protein 1;
PYROXD1
pyridine nucleotide-disulphide oxidoreductase domain 1
PYROXD1;pyridine nucleotide-disulphide oxidoreductase domain 1;26162;ENSG00000121350;12p12.1;FLJ22028;pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1;pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1;EC 1.8.1.-;
WFDC10B
WAP four-disulfide core domain 10B
WFDC10B;WAP four-disulfide core domain 10B;20479;ENSG00000182931;WAP12;20q13.12;protein WFDC10B;protein WFDC10B;protease inhibitor WAP12;
Npc1l1
NPC1 (Niemann-Pick disease, type C1, gene)-like 1
NPC1L1;NPC1 (Niemann-Pick disease, type C1, gene)-like 1;chromosome: 14;Niemann-Pick C1-like protein 1;Niemann-Pick C1-like protein 1;NPC1-like 1;Niemann-Pick disease, type C1-like 1;
DLGAP3
discs, large (Drosophila) homolog-associated protein 3
DLGAP3;discs, large (Drosophila) homolog-associated protein 3;30368;ENSG00000116544;DAP3;SAPAP3;1p35.3-p34.1;disks large-associated protein 3;disks large-associated protein 3;DAP-3;PSD-95/SAP90-binding protein 3;SAP90/PSD 95 associated protein 3;SAP90/PSD-95-associated protein 3;
ENOX2
ENOX2 ecto-NOX disulfide-thiol exchanger 2 [ Homo sapiens ]
ecto-NOX disulfide-thiol exchanger 2; 2259; Ensembl:ENSG00000165675; APK1 antigen; cytosolic ovarian carcinoma antigen 1; tumor-associated hydroquinone oxidase; APK1; tNOX; COVA1;
Adam6
a disintegrin and metallopeptidase domain 6
Adam6; TMDCIV; a disintegrin and metallopeptidase domain 6; tMDC IV; a disintegrin and metalloproteinase domain 6;
Discovery and Translational Service
Creative BioMart is a leader in protein accelerated protein discovery and translational services with expertise and proprietary technologies for protein array, epitope mapping and radioimmunoassay. Leveraging our technologies together with specialized protein assay, Creative BioMart is excellent in...
Drug Discovery Screening
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new drug candidate and therapies are discovered and developed. At Creative BioMart, our team are motivated to shares creativity and passion with our clients and is dedicated ourselves to discovery and d...
Cell-free Display Platform
Many types of cell-free approaches have been developed for directed evolution in which the presence of cells is not required. For example, ribosome display, mRNA display, aptamers, in vitro compartmentalization (IVC), cis-activity based (CIS) display and covalent antibody display (CAD) are, among ot...
<em>Escherichia coli</em> Display Platform
E. coli, as a type of Gram-negative bacteria, is the most widely used cell display system in directed evolution. Since the first use for recombinant protein production, this system has been employed to display various proteins/peptides. With the power of high-throughput technologies, such as magneti...
Phage Display Platform
Phage display, first described by George P. Smith in 1985, is a powerful laboratory technique applied in directed evolution. Since the first report on phage display and selection of human antibodies in 1991, this technology is now widely used. Today, antibody libraries containing millions of antibod...
Special Cell-based Display Platform
Besides commonly used hosts, such as E. coli, yeast and phage, there are other cells that can also be used for protein display, although not widely employed. Gram-positive bacteria display method, for example, is playing a special role in directed evolution. Because of the rigid structure of their c...
Yeast Display Platform
Yeast display, first published by Professor K. Dane Wittrup in 1997, is a protein engineering technique that uses the expression of recombinant proteins incorporated into the cell wall of yeast for isolating and engineering antibodies. Saccharomyces cerevisiae, a species of yeast, is one of the most...
Membrane Protein Platform: Nanodisc
Membrane proteins play an essential role in exchanging material, information, and energy between cells and the external environment and are one of the current research hotspots. However, since membrane proteins have hydrophobic moieties and are easily polymerized in vitro, it is necessary to find a ...
Nanodisc Technology Platform
Nanodiscs are discoidal lipid bilayers 8-16 nm in diameter stabilized and solubilized in aqueous solution by two encircling amphipathic helical protein ribbons (called membrane scaffolding proteins). The size of the Nanodisc is determined by the length of the membrane scaffolding proteins and the ra...
Diagnose Parkinson's disease in Two Minutes
Every year in the United States, there are 50,000 newly diagnosed Parkinson's disease. It is a neurological disorder. When nerve cells in brain stop generating dopamine, the Parkinson's disease will occur as the dopamine helps control muscle movement. Without dopamine, the nerve cells cannot properl...
Nature: Fighting Alzheimer's Disease from the Perspective of Immune Transmitter
Nov. is the national Alzheimers disease (AD) Awareness Month for America. And it widely affects old people around the world. It is one of the common forms of dementia. According to some statistics, every seven second, there will be one people suffer AD. In Germany and Switzerland alone, around 1.5...
A New Nanotechnology Brings Hope for MS and Other Immune-related Diseases
Multiple sclerosis (MS), a nervous system disease, affects brain and spinal cord. It damages the myelin sheath. This damage slows down or blocks messages between brain and body, leading to the symptoms of MS. Patients suffering from MS deal with everything from numb limbs to blindness or paralysis...
CardiovascularDisease & Softening Arteries
Softening Arteries and Protecting the Heart: the correlation between Cholesterol and Atherosclerosis Collagen production (stained red) in aortic smooth muscle cells. The cell nuclei are stained blue. (Credit: Richard K. Assoian, PhD) One of the main risk factors for cardiovascular disease is art...
Patients with Digestive Diseases Gain Hope for Selective Therapies by Targeting Specific Neurotransmitter
Recently, Penn State College of Medicine researchers did some studies regarding neuroscience. They found separate nerve pathways regulate diverse organ functions along the upper gastrointestinal (GI) tract, which is different from what researchers found in past studies. The lead investigator of this...
IFIT Protein: Its Molecular Mechanism on Distinguishing Viral RNA only
IFIT protein, an anti-virus protein, allows the human immune system to detect viruses and prevent infection. It services as foot soldiers guarding the body against infection. It recognizes foreign viral ribonucleic acid (RNA) produced by the virus and acts as defender molecules by potentiall...
Cell: Scientists Found another Role of Enzyme Superoxide Dismutase
Since 1960s, the initial discovery of Superoxide dismutase (SOD1), an enzyme that was believed having solo role in protecting living cells against damage from free radicals by scientists. The enzyme is present in all living cells, from the most ancient bacteria to every cell in the human body. ...
Blood: A New Immune “Rare Disease” Has Been Identified
Recently a paper on the Blood journal revealed that a research group found a new kind of B-cell defect, which stated that severe autoimmunity in childhood can be an indication of a primary immunodeficiency (PID). The result was gained on a 13-year-old patient with the novel genetic technology. ...
Scientists Innovatively Modified an Approach to Dissect Kinases
The top is a structural model of uniRapR domain which binds small molecule rapamycin. The bottom left depicts inactive state of the protein of interest modified with uniRapR domain. Binding of rapamycin and uniRapR reactivates the protein (bottom right). The approach mentioned here i...
Researchers Discovered the Energy and Pathway of Opening and Closing of Ion Channel
Ion channelsare pore-formingmembraneproteins. They are important components in many biological processes that involve rapid changes in cells, for example,cardiac,skeletal, andsmooth musclecontraction,epithelialtransport of nutrients and ions,T-cellactivation andpancreaticbeta-cellinsulinrele...
An Important Discovery on Mitochondrion Channels
It is known that dysfunction of protein transporters might cause diseases, such as cardiovascular or cancer. But with many studies, there is still no clear mechanism. In a recent study, researchers explored a channel complex and relevant membrane proteins. The channel complex, namely the transloc...
Nature Genetics: the Mapping of Telomerase was Disclosed for the First Time
Telomerase is an important enzyme that adds DNA sequence repeats to the 3 end of DNA strands in the telomere region. It is one of the fundamental enzymes in cell biology. It is a reverse transcriptase and shortened after every replication cycle. In 1970s, scientists have assumed that it was ...
The Translational Kinase Tumor Inhibitor Discovery Consortium between Six Partners
On April 10, 2013, SARomics Biostructures, Prestwick Chemical and ProQinase together with the University of Turin, Italy, the Israel Structural Proteomics Center (ISPC) and the TechMedIll platform of the University of Strasbourg announced that they have created the Translational Kinase Tumor Inhibit...
Discussion on the Prospect of Biosimilar Monoclonal Antibodies Drugs
In the past few years, monoclonal antibody drugs have dominated the world's largest bio-pharmaceutical drug sales, and in the coming years, monoclonal antibody drugs will continue to be the main force. The rapid development of monoclonal antibody drugs as well as the approaching of patent expirat...
Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part
Google once said it wanted to declare war against disease. When it said so, 23andMe, invested by it has serviced 200,000 people; iPierian (mainly for stem cells), invested by it was facing a big moment. Thus we dont need to feel surprised when we hear about that Google is going to set up a new compa...
EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
On last Tuesday, EU regulators announced another pecuniary penalty event on pharmaceutical giant Johnson Johnson and Novartis because they tried to stop the selling launch of a cheaper painkiller biosimilar. They have to accept a fine of 16.3 million (i.e. $ 22 million); meanwhile European Commissi...
What Biopharmaceutical Innovations and New Drug Discovery Bring?
There is no exact definition for innovation. While there at least should be a substantial improvement and not a small change over what is currently available, for example, the growth and maturation of high throughput screening and microarray technique. The Biopharmaceutical and drug discovery...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
XI Discussions in Structural Molecular Biology
When March, 14 March 16, 2013 Where Ubytovn, wellness hotel Rezidence Nov Hrady, in the Academic conference center Nov zmek Introduction Structural biology is a branch of molecular biology, biochemistry, and biophysics concerned with the molecular structure of biological macromol...
The Optimize 2013: Antibody Engineering & Discovery Conference
When 25 Feb. 2013 to 27 Feb. 2013 Where Maritim Hotel Frankfurt, Theodor-Heuss-Allee , Frankfurt, Germany Introduction With many antibody companies facing shared cha...
A New Patent of Monoclonal Antibodies for the Treatment of Serious Diseases Research and Development Registered
On Dec. 21, 2012, one of our peer companies, Immunomedics, Inc. (Nasdaq:IMMU) announced that it has received notice its patent application for Anti-CD19 antibodies which would be issued as US patent No. 8,337,840 on Dec. 25, 2012. IMMU primarily attaches importance to the development o...
The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. On Nov. 8, 2012, the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) completed the New Drug Application (NDA) for insulin degludec...
FDA Nod for the First Drug-eluting Stent to Treat Peripheral Arterial Disease
On Nov. 15, 2012, The U.S. Food and Drug Administration (FDA) approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent) to treat peripheral artery disease (PAD) symptoms. This is the first drug-eluting stent to treat PAD. PAD is a progressive process that fatty material (plaque) bu...
